Related Experiment Video
Updated: Dec 18, 2025

Murine Model of Intestinal Ischemia-reperfusion Injury
Published on: May 11, 2016
MicroRNA-674-5p induced by HIF-1α targets XBP-1 in intestinal epithelial cell injury during endotoxemia
Zhihao Liu1, Jie Jiang2, Weigang Dai3
1Division of Emergency Medicine, Department of General Internal Medicine, Department of Emergency Intensive Care Unit, The First Affiliated Hospital of Sun Yat-sen University, No.58, Zhongshan 2nd Road, 510080 Guangzhou, China.
Abstract:
Intestinal mucosal integrity dysfunction during endotoxemia can contribute to translocation of intestinal bacteria and a persistent systemic inflammatory response, which both fuel the pathophysiological development of sepsis or endotoxemia. The pathogenesis of intestinal damage induced by endotoxemia remains poorly understood. Here, we identified the microRNA (miR)-674-5p/X-box binding protein 1 (XBP-1) axis as a critical regulator and therapeutic target in preventing intestinal crypt cell proliferation during endotoxemia. MiR-674-5p was markedly increased in intestinal epithelial cells (IECs) during endotoxemia and its induction depended on hypoxia-inducible factor-1α (HIF-1α). Intriguingly, gene expression microanalysis revealed that expression of XBP-1 was down-regulated in IECs with over-expression of miR-674-5p. miR-674-5p was found to directly target XBP-1 protein expression. Upon in vitro, anti-miR-674-5p enhanced sXBP-1 expression and facilitated intestinal crypt cell proliferation. Blockade of miR-674-5p promoted XBP-1 activity, attenuated intestinal inflammation, and expedited intestinal regeneration, resulting in protection against endotoxemia-induced intestinal injury in mice. More importantly, the survival in endotoxemia mice was significantly improved by inhibiting intestinal miR-674-5p. Collectively, these data indicate that control of a novel miR-674-5p/XBP-1 signaling axis may mitigate endotoxemia -induced intestinal injury.
Insights
Researchers discovered that inhibiting microRNA-674-5p (miR-674-5p) protects against endotoxemia-induced intestinal injury by targeting the X-box binding protein 1 (XBP-1) pathway, improving survival in mice.
Area of Science:
- Gastroenterology
- Molecular Biology
- Immunology
Background:
- Intestinal barrier dysfunction during endotoxemia contributes to sepsis development.
- The precise mechanisms of endotoxemia-induced intestinal damage are not fully understood.
Purpose of the Study:
- To identify key regulators of intestinal damage during endotoxemia.
- To explore the microRNA-674-5p/X-box binding protein 1 (XBP-1) axis as a therapeutic target.
Main Methods:
- Investigated microRNA-674-5p (miR-674-5p) and X-box binding protein 1 (XBP-1) expression in intestinal epithelial cells (IECs) during endotoxemia.
- Utilized in vitro cell culture and in vivo mouse models of endotoxemia.
- Assessed the impact of miR-674-5p inhibition on intestinal crypt cell proliferation, inflammation, and survival.
Main Results:
- MiR-674-5p expression was upregulated in IECs during endotoxemia, dependent on hypoxia-inducible factor-1α (HIF-1α).
- MiR-674-5p directly targets and downregulates XBP-1 expression.
- Inhibition of miR-674-5p enhanced XBP-1 activity, promoted intestinal crypt cell proliferation, attenuated inflammation, and improved survival in endotoxemia mouse models.
Conclusions:
- The miR-674-5p/XBP-1 signaling axis is a critical regulator of intestinal injury during endotoxemia.
- Targeting this axis offers a potential therapeutic strategy for mitigating endotoxemia-induced intestinal damage and improving patient outcomes.
More Related Videos
Related Concept Videos
Regulation of the Unfolded Protein Response
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

